Drug Screening Market to Reach USD 29.7 Billion by 2032 Driven by Rising Drug and Alcohol Consumption | Report by S&S Insider
06 nov. 2024 07h33 HE
|
SNS Insider pvt ltd
Austin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Drug Screening Market was valued at USD 7.6 Billion in 2023 and is projected to reach USD 29.7 Billion by...
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
31 oct. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
Intelligent Bio Solutions has partnered with B2i Digital to execute an investor communications program.
Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil
24 oct. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS announces one year of enhanced workplace safety with Mount Anvil following the integration of fingerprint drug testing.
U.S. Employer and Workplace Drug Testing Market Report 2024, Featuring First Advantage, Labcorp, Dragerwerk, Quest Diagnostics, Cordant Health Solutions, HireRight, Omega Laboratories & Psychemedics
15 oct. 2024 09h41 HE
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "U.S. Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type (Pre-Employment Drug Screens), Product, Mode, Drug,...
Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution
09 oct. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS announces its distribution partnership with Spirit Group, an Australian, Indigenous-owned marketing and consulting agency.
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services
01 oct. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS announces the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
27 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS successfully completes in-clinic testing proposed to the FDA earlier this year in its clinical study plan.
Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031 | SkyQuest Technology
27 sept. 2024 08h30 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of 16.5% during the forecast...
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
26 sept. 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, announces the release of its first-ever Education Insights Report.
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
25 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...